Erythromycin inhibits the assembly of the large ribosomal subunit in growing Escherichia coli cells
The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
Abstract
Erythromycin and other macrolide antibiotics have been examined for their effects on ribosome assembly in growing Escherichia coli cells. Formation of the 50S ribosomal subunit was specifically inhibited by erythromycin and azithromycin. Other related compounds tested, including oleandomycin, clarithromycin, spiramycin, and virginiamycin M1, did not influence assembly. Erythromycin did not promote the breakdown of ribosomes formed in the absence of the drug. Two erythromycin-resistant mutants with alterations in ribosomal proteins L4 and L22 were also examined for an effect on assembly. Subunit assembly was affected in the mutant containing the L22 alteration only at erythromycin concentrations fourfold greater than those needed to stop assembly in wild-type cells. Ribosomal subunit assembly was only marginally affected at the highest drug concentration tested in the cells that contained the altered L4 protein. These novel results indicate that erythromycin has two effects on translation, preventing elongation of the polypeptide chain and also inhibiting the formation of the large ribosomal subunit.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Iron is also strongly implicated in non-alcoholic steatohepatitis, considered an early marker of insulin resistance [622-624].”
Citations
Cites
The Molecular Basis of Antibiotic Action
Gale, E. F. (1981) · Medical Entomology and Zoology · Cited by 1,217
The ribosome: Structure, function and evolution
Edward, B., & Baden, H. (1991) · Trends in Biochemical Sciences · doi:10.1016/0968-0004(91)90126-g · Cited by 508
Retsema, J., Girard, A., Schelkly, W., Manousos, M., Anderson, M., Bright, G., Borovoy, R., Brennan, L., & Mason, R. (1987) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.31.12.1939 · Cited by 464 · cited 1×
“However, azithromycin, a novel 15-membered erythromycin derivative [34, 47], was as effective as erythromycin in inhibiting subunit assembly (Fig.”
BackgroundMoazed, D., & Noller, H. F. (1987) · Biochimie · doi:10.1016/0300-9084(87)90215-x · Cited by 335 · cited 2×
“Sequence analysis and protection studies have also indicated that changes in domain II of the secondary structure of 23S RNA can also give rise to erythromycin resistance [16, 23].”
BackgroundInhibitors of protein biosynthesis
(2006) · Biochemistry and Molecular Biology of Antimicrobial Drug Action · doi:10.1007/0-387-27566-5_5 · Cited by 318
Skinner, R., Cundliffe, E., & Schmidt, F. J. (1983) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)44232-3 · Cited by 263 · cited 1×
“Methylation of a single adenine residue in domain V can confer drug resistance in several different organisms [37].”
BackgroundInhibitors of Protein Biosynthesis
Vázquez, D. (1979) · Molecular Biology Biochemistry and Biophysics · doi:10.1007/978-3-642-81309-2 · Cited by 238 · cited 1×
“Lincomycin, the 16-membered macrolide spiramycin, and the streptogramin A compound viriginiamycin M1 are also antibiotics that affect translation at a step or site related to that inhibited by the macrolides [44].”
BackgroundGuthrie, C., Nashimoto, H., & Nomura, M. (1969) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.63.2.384 · Cited by 184
Vaara, M. (1993) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.37.2.354 · Cited by 170 · cited 1×
“It is also important to note that in a number of different organisms, the efficacy of erythromycin and azithromycin in vivo is much greater than that of oleandomycin or spiramycin, consistent with a potential additional effect of the former compounds [25, 42, 47].”
BackgroundWittmann, H. G., Stöffler, G., Apirion, D., Rosen, L., Tanaka, K., Tamaki, M., Takata, R., Dekio, S., Otaka, E., & Osawa, S. (1973) · Molecular and General Genetics MGG · doi:10.1007/bf00333665 · Cited by 169 · cited 4×
“Strain N281 has a mutation affecting protein L22, and strain N282 is altered in protein IA [49].”
BackgroundInfluential
Research works printed but not linked: 7
- Apirion D (1967) Three genes that affect Escherichia coli ribosomes. J Mol Biol 30:255?275
- Cundliffe E (1980) Antibiotics and prokaryotic ribosomes: action, interaction and resistance. In: Chambliss G, Craven GR, Davies J, Davis K, Kahan L, Nomura M (eds). Ribosomes, structure, function and genetics. Baltimore: University Park Press, pp 555?581
- Cundliffe E (1990) Recognition sites for antibiotics within rRNA. In: Hill WE, Dahlberg A, Garrett RA, Moore PB, Schlessinger D, Warner JR (eds), The ribosome: structure, function and evolution. Washington, DC: Am Soc Microbiol, pp 479?490
- Nakagawa A, Omura S (1984) Structure and stereochemistry of macrolides. In: Omura S (ed), Macrolide antibiotics. Orlando, FL: Academic Press, pp 37?84
- Nakayama I (1984) Macrolides in clinical practice. In: Omura S (ed), Macrolide antibiotics Orlando, FL: Academic Press, pp 261?300
- Omura S (1984) Macrolide antibioties. Orlando, FL: Academic Press
- Omura S, Tanaka H (1984) Production and antimicrobial activity of macrolides. In: Omura S (ed), Macrolide antibiotics. Orlando, FL: Academic Press, pp 3?35
Cited by
Kell, D. B. (2009) · BMC Medical Genomics · doi:10.1186/1755-8794-2-2 · Cited by 554
“Iron is also strongly implicated in non-alcoholic steatohepatitis, considered an early marker of insulin resistance [532-534].”
BackgroundThe macrolide antibiotic renaissance
Dinos, G. P. (2017) · British Journal of Pharmacology · doi:10.1111/bph.13936 · Cited by 471
“Champney and co-workers have shown that macrolides inhibit ribosome assembly (Chittum and Champney, 1995; Champney and Miller, 2002; Champney and Pelt, 2002), but this results from a secondary effect due to the inhibition of synthesis of ribosomal proteins (Siibak et al., 2009).”
BackgroundTait-Kamradt, A., Davies, T., Cronan, M., Jacobs, M. R., Appelbaum, P. C., & Sutcliffe, J. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.8.2118-2125.2000 · Cited by 281
Tait-Kamradt, A., Davies, T., Appelbaum, P. C., Depardieu, F., Courvalin, P., Petitpas, J., Wondrack, L., Walker, A., Jacobs, M. R., & Sutcliffe, J. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.12.3395-3401.2000 · Cited by 260
Macrolide Antibiotics: Binding Site, Mechanism of Action, Resistance
Gaynor, M., & Mankin, A. (2003) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026033452159 · Cited by 235
“Interference with ribosome assembly may contribute further to the overall inhibitory activity of macrolides [38,39].”
Background
Metadata
- Authors
- Chittum, H. S., & Champney, W. S.
- Affiliations
- East Tennessee State University (US)
- Venue
- Current Microbiology
- Published
- 1995-05
- Volume
- 30
- Issue
- 5
- Pages
- 273-279
- ISSN
- 0343-8651 (ISSN-L)
- 1432-0991
- OpenAlex
- W2070110265
- Cited by
- 88
- References
- 46
- Citations by year
- 2026: 3 · 2025: 2 · 2024: 1 · 2023: 1 · 2022: 3 · 2021: 2 · 2020: 1 · 2019: 3 · 2018: 3 · 2017: 2 · 2016: 2 · 2015: 4 · 2014: 2 · 2013: 2 · 2012: 3
- FWCI
- 1.11
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Current Microbiology (publishedVersion)
- PubMed (publishedVersion)
- Digital Commons - East Tennessee State University (East Tennessee State University) (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA and protein synthesis mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Bacterial Genetics and Biotechnology
- Life Sciences › Immunology and Microbiology › Applied Microbiology and Biotechnology › Microbial Natural Products and Biosynthesis
- Keywords
- erythromycin, macrolide antibiotics, ribosome assembly, 50S ribosomal subunit, Escherichia coli, ribosomal protein L22, ribosomal protein L4, erythromycin resistance, ribosomal proteins
- MeSH terms
- Anti-Bacterial Agents, Drug Resistance, Microbial, Erythromycin, Escherichia coli, Mutation, Peptide Chain Elongation, Translational, Ribosomal Proteins, Ribosomes, Structure-Activity Relationship, Protein Biosynthesis, RNA-Binding Proteins, Azithromycin, Escherichia coli Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Erythromycin inhibits the assembly of the large ribosomal subunit in growing Escherichia coli cells. https://app.cochat.ai/papers/10.1007/bf00295501
- The paper
- Chittum, H. S., & Champney, W. S. (1995). Erythromycin inhibits the assembly of the large ribosomal subunit in growing Escherichia coli cells. Current Microbiology. https://doi.org/10.1007/bf00295501
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.